Who We Are

National Genetics Institute (NGI) is a wholly owned subsidiary of Laboratory Corporation of America® Holdings (LabCorp®). NGI provides advanced genetics testing services for blood screening, medical testing, and clinical research. The company offers industry leading assays for human immunodeficiency virus (HIV), hepatitis A, B, and C (HAV, HBV, and HCV) viruses and other infectious agents and has pioneered robust, sensitive, and high throughput methods for pooled specimen nucleic acid testing.

NGI is a leading provider of nucleic acid screening services to the global biotechnology industry and screens millions of plasma donations a year for infectious agents. The company also provides genetic testing services to physicians, hospitals, and clinics and has supported numerous pharmaceutical and biotechnology companies in the clinical development of infectious disease and oncology therapies.

NGI is licensed as a clinical laboratory provider by both state and federal agencies, participates in a number of approved quality control programs, and holds active Biologics Licenses from the US Food and Drug Administration (FDA) for screening of plasma for blood borne infectious agents.

We employ a talented and diverse scientific and medical team with substantial experience in nucleic acid testing, PCR methods, genetics, virology, and infectious disease in addition to a team of clinical pathologists specializing in dermatopathology and gastrointestinal pathology providing services through Dianon Systems.


Meet the Scientific Team
Jeffrey Albrecht, Ph.D.
Wenjiang Chu, M.D., Ph.D.
Françoise Gala, Ph.D.
Kiat Chan, M.D.
Honggang Shen, M.D.
Frank Luo, M.D.
Lyndon Su, M.D.
Yong Tao, M.D.
Alicia Collado-Hidalgo, Ph.D.